Geode Capital Management LLC Grows Stock Holdings in Microbot Medical Inc. (NASDAQ:MBOT)

Geode Capital Management LLC raised its stake in Microbot Medical Inc. (NASDAQ:MBOT) by 7.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 142,659 shares of the biotechnology company’s stock after buying an additional 10,442 shares during the period. Geode Capital Management LLC owned approximately 0.70% of Microbot Medical worth $160,000 at the end of the most recent reporting period.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $9.00 price objective on shares of Microbot Medical in a research note on Thursday, April 10th.

Microbot Medical Stock Down 1.2 %

Microbot Medical stock opened at $2.39 on Friday. The firm has a market capitalization of $83.04 million, a PE ratio of -2.99 and a beta of 1.40. The firm’s 50-day simple moving average is $1.81 and its 200 day simple moving average is $1.53. Microbot Medical Inc. has a 52 week low of $0.82 and a 52 week high of $3.38.

Microbot Medical (NASDAQ:MBOT) last issued its quarterly earnings data on Wednesday, March 26th. The biotechnology company reported ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.02). On average, research analysts expect that Microbot Medical Inc. will post -0.71 EPS for the current fiscal year.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.